OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HXZS56

Hexza Corp Bhd

Specialty ChemicalsVerified

Hexza Corp Bhd maintains a strong liquidity position, with a current ratio of 22.63, indicating that its current assets significantly exceed its current liabilities. The company holds MYR 35.85 million in cash and equivalents, while its total liabilities amount to only MYR 12.82 million, and it has no long-term debt. This liquidity profile supports operational flexibility and financial stability. The company's profitability is modest, with a return on equity (ROE) of 0.4% and a return on assets (ROA) of 0.39%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that Hexza Corp Bhd may not be generating returns at a level that outperforms its cost of capital. The net income of MYR 1.68 million on total assets of MYR 434.29 million indicates a low margin of profitability. Hexza Corp Bhd's revenue is concentrated in a single geographic market, Malaysia, as disclosed in its financial reporting. The company does not report segment-specific revenue, but its operations are primarily localized, which may expose it to regional economic and regulatory risks. There is no indication of international diversification in the available data. The company's growth trajectory appears to be constrained, with no significant revenue growth or capital expenditure reported in the latest financial period. Capital expenditure was negative at MYR -1.76 million, suggesting a reduction in investment in physical assets. The operating cash flow is also negative at MYR -177,000, which may indicate inefficiencies in working capital management or operational performance. Risk factors for Hexza Corp Bhd are currently low, with no immediate liquidity or dilution flags detected in the risk assessment. The company has no long-term debt and a low dilution risk, as the number of basic and diluted shares outstanding is identical. However, the low ROE and ROA suggest that the company may need to improve its operational efficiency or expand its market reach to enhance returns. Recent financial filings and transcripts do not indicate any major corporate events or strategic shifts for Hexza Corp Bhd. The company's last actual EPS was reported at MYR 0.02, which is consistent with a low-profit margin business model. There are no notable earnings surprises or guidance changes in the latest reporting period.

30-day price · HXZS+0.07 (+7.5%)
Low$0.85High$0.94Close$0.94As of13 May, 00:00 UTC
Profile
CompanyHexza Corp Bhd
TickerHXZS.KL
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Hexza Corp Bhd is a specialty chemicals company that produces and distributes chemical products, primarily serving industrial and consumer markets in Malaysia.

Classification. Hexza Corp Bhd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Hexza Corp Bhd maintains a strong liquidity position, with a current ratio of 22.63, indicating that its current assets significantly exceed its current liabilities. The company holds MYR 35.85 million in cash and equivalents, while its total liabilities amount to only MYR 12.82 million, and it has no long-term debt. This liquidity profile supports operational flexibility and financial stability. The company's profitability is modest, with a return on equity (ROE) of 0.4% and a return on assets (ROA) of 0.39%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that Hexza Corp Bhd may not be generating returns at a level that outperforms its cost of capital. The net income of MYR 1.68 million on total assets of MYR 434.29 million indicates a low margin of profitability. Hexza Corp Bhd's revenue is concentrated in a single geographic market, Malaysia, as disclosed in its financial reporting. The company does not report segment-specific revenue, but its operations are primarily localized, which may expose it to regional economic and regulatory risks. There is no indication of international diversification in the available data. The company's growth trajectory appears to be constrained, with no significant revenue growth or capital expenditure reported in the latest financial period. Capital expenditure was negative at MYR -1.76 million, suggesting a reduction in investment in physical assets. The operating cash flow is also negative at MYR -177,000, which may indicate inefficiencies in working capital management or operational performance. Risk factors for Hexza Corp Bhd are currently low, with no immediate liquidity or dilution flags detected in the risk assessment. The company has no long-term debt and a low dilution risk, as the number of basic and diluted shares outstanding is identical. However, the low ROE and ROA suggest that the company may need to improve its operational efficiency or expand its market reach to enhance returns. Recent financial filings and transcripts do not indicate any major corporate events or strategic shifts for Hexza Corp Bhd. The company's last actual EPS was reported at MYR 0.02, which is consistent with a low-profit margin business model. There are no notable earnings surprises or guidance changes in the latest reporting period.
Key takeaways
  • Hexza Corp Bhd has a strong liquidity position with a current ratio of 22.63 and no long-term debt.
  • The company's profitability is low, with ROE and ROA at 0.4% and 0.39%, respectively.
  • Revenue is concentrated in Malaysia, with no indication of international diversification.
  • Growth appears limited, with negative capital expenditure and negative operating cash flow.
  • Risk factors are currently low, with no immediate liquidity or dilution concerns.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$14.4M
Gross profit
Operating income$2.0M
Net income$1.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$177.0k
CapEx-$1.8M
Free cash flow$917.0k
Total assets$434.3M
Total liabilities$12.8M
Total equity$421.5M
Cash & equivalents$35.8M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$75.4M$12.6M$10.2M-$4.1M
FY-3$77.2M$7.1M$5.9M-$9.0M
FY-2$60.0M$7.1M$6.1M-$984.3k
FY-1$55.5M$7.2M$7.0M-$21.5M
FY0$59.3M$906.8k$465.4k-$45.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$300.3M$281.1M$97.0M
FY-3$268.8M$254.2M$80.1M
FY-2$363.9M$349.4M$69.7M
FY-1$481.4M$468.7M$18.0M
FY0$480.3M$451.9M$19.0M
PeriodOCFCapExFCFSBC
FY-4$16.4M-$1.4M-$4.1M
FY-3$28.4k-$2.0M-$9.0M
FY-2$8.4M-$1.1M-$984.3k
FY-1$9.2M-$20.2M-$21.5M
FY0$4.4M-$32.8M-$45.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$14.4M$2.0M$1.7M$917.0k
FQ-6$14.9M$1.6M$2.5M-$15.7M
FQ-5$15.8M$1.7M$1.4M-$6.0M
FQ-4$17.0M$1.0M$821.0k-$4.9M
FQ-3$13.0M-$1.2M-$1.1M-$12.6M
FQ-2$13.4M-$828.3k-$696.6k-$6.9M
FQ-1$18.0M$687.0k$349.0k$1.3M
FQ0$20.2M$2.0M$994.0k$2.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$434.3M$421.5M$35.8M
FQ-6$481.4M$468.7M$18.0M
FQ-5$431.4M$416.1M$21.4M
FQ-4$452.6M$440.6M$17.3M
FQ-3$405.2M$392.1M$13.1M
FQ-2$480.3M$451.9M$19.0M
FQ-1$517.3M$499.0M$22.2M
FQ0$504.6M$477.9M$29.4M
PeriodOCFCapExFCFSBC
FQ-7-$177.0k-$1.8M$917.0k
FQ-6$9.2M-$20.2M-$15.7M
FQ-5$4.1M-$7.9M-$6.0M
FQ-4$6.0M-$14.3M-$4.9M
FQ-3$5.2M-$26.3M-$12.6M
FQ-2$4.4M-$32.8M-$6.9M
FQ-1-$8.4M-$287.0k$1.3M
FQ0-$8.0M-$728.0k$2.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$421.5M
Net cash$35.8M
Current ratio22.6
Debt/Equity0.0
ROA0.4%
ROE0.4%
Cash conversion-11.0%
CapEx/Revenue-12.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricHXZSActivity
Op margin14.2%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin11.7%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-12.2%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity0.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Last actual EPS0.02 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:04 UTC#4013f65a
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 04:10 UTCJob: 50272011